EXCHANGE AGREEMENTExchange Agreement • March 26th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 26th, 2015 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (the “Agreement”), dated as of March 25, 2015 (the “Effective Date”), is made by and between MabVax Therapeutics Holdings, Inc., a Delaware corporation (“Company”), and the holder of the Company’s Series B Preferred Stock and Series B Warrants signatory hereto (“Holder”).